151 related articles for article (PubMed ID: 19550394)
21. EBNA2 and Its Coactivator EBNA-LP.
Kempkes B; Ling PD
Curr Top Microbiol Immunol; 2015; 391():35-59. PubMed ID: 26428371
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
Bazot Q; Paschos K; Allday MJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
[TBL] [Abstract][Full Text] [Related]
23. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
24. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
[TBL] [Abstract][Full Text] [Related]
25. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells.
Allday MJ; Bazot Q; White RE
Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372
[TBL] [Abstract][Full Text] [Related]
26. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
[TBL] [Abstract][Full Text] [Related]
27. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus.
Saha A; Robertson ES
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971472
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events.
Zhao B
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112815
[TBL] [Abstract][Full Text] [Related]
30. [Epstein-barr virus gene expression in latent infection and B-lymphocyte growth transformation].
Harada S
Uirusu; 2002 Jun; 52(1):129-34. PubMed ID: 12227161
[No Abstract] [Full Text] [Related]
31. Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.
Zychlinska M; Herrmann H; Zimber-Strobl U; Hammerschmidt W
PLoS One; 2008 Apr; 3(4):e1996. PubMed ID: 18414672
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
[TBL] [Abstract][Full Text] [Related]
33. Burkitt lymphoma--a stalking horse for cancer research?
Klein G
Semin Cancer Biol; 2009 Dec; 19(6):347-50. PubMed ID: 19607918
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro.
Chen A; Divisconte M; Jiang X; Quink C; Wang F
J Virol; 2005 Apr; 79(7):4506-9. PubMed ID: 15767450
[TBL] [Abstract][Full Text] [Related]
36. Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation.
Zhang Y; Zhao H; He X; Zheng S; Wang T; Yan D; Sun J; Lu X; Wen J; Lau WY
Sci China Life Sci; 2012 Aug; 55(8):735-43. PubMed ID: 22932889
[TBL] [Abstract][Full Text] [Related]
37. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.
Hertle ML; Popp C; Petermann S; Maier S; Kremmer E; Lang R; Mages J; Kempkes B
PLoS Pathog; 2009 Jul; 5(7):e1000506. PubMed ID: 19578441
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival.
Wang LW; Wang Z; Ersing I; Nobre L; Guo R; Jiang S; Trudeau S; Zhao B; Weekes MP; Gewurz BE
PLoS Pathog; 2019 Sep; 15(9):e1008030. PubMed ID: 31518366
[TBL] [Abstract][Full Text] [Related]
39. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.
Westhoff Smith D; Sugden B
Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328
[TBL] [Abstract][Full Text] [Related]
40. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
